Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102


Sonic Hedgehog and WNT Signaling Promote Adrenal Gland Regeneration in Male Mice.

Finco I, Lerario AM, Hammer GD.

Endocrinology. 2018 Feb 1;159(2):579-596. doi: 10.1210/en.2017-03061.


Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1.

Xing Y, Morohashi KI, Ingraham HA, Hammer GD.

Development. 2017 Oct 15;144(20):3798-3807. doi: 10.1242/dev.150516. Epub 2017 Sep 11.


Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex.

Lerario AM, Finco I, LaPensee C, Hammer GD.

Front Endocrinol (Lausanne). 2017 Mar 23;8:52. doi: 10.3389/fendo.2017.00052. eCollection 2017. Review.


Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Penny MK, Finco I, Hammer GD.

Mol Cell Endocrinol. 2017 Apr 15;445:42-54. doi: 10.1016/j.mce.2016.12.005. Epub 2016 Dec 8. Review.


Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 Aug 8;30(2):363. doi: 10.1016/j.ccell.2016.07.013. Epub 2016 Aug 8. No abstract available.


Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.

Nanba K, Omata K, Tomlins SA, Giordano TJ, Hammer GD, Rainey WE, Else T.

Eur J Endocrinol. 2016 Aug;175(2):K1-6. doi: 10.1530/EJE-16-0262. Epub 2016 May 10.


Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Erratum in: Cancer Cell. 2016 Aug 8;30(2):363.


ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs.

LaPensee CR, Mann JE, Rainey WE, Crudo V, Hunt SW 3rd, Hammer GD.

Endocrinology. 2016 May;157(5):1775-88. doi: 10.1210/en.2015-2052. Epub 2016 Mar 17.


Molecular Heterogeneity in Aldosterone-Producing Adenomas.

Nanba K, Chen AX, Omata K, Vinco M, Giordano TJ, Else T, Hammer GD, Tomlins SA, Rainey WE.

J Clin Endocrinol Metab. 2016 Mar;101(3):999-1007. doi: 10.1210/jc.2015-3239. Epub 2016 Jan 14.


Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ.

J Clin Endocrinol Metab. 2016 Feb;101(2):364-89. doi: 10.1210/jc.2015-1710. Epub 2016 Jan 13. Review.


Nutritional conditions regulate transcriptional activity of SF-1 by controlling sumoylation and ubiquitination.

Lee J, Yang DJ, Lee S, Hammer GD, Kim KW, Elmquist JK.

Sci Rep. 2016 Jan 11;6:19143. doi: 10.1038/srep19143.


5th International ACC Symposium: Introduction.

Hammer GD.

Horm Cancer. 2016 Feb;7(1):1-2. doi: 10.1007/s12672-015-0248-8. Epub 2016 Jan 4. No abstract available.


Mouse models of adrenocortical tumors.

Basham KJ, Hung HA, Lerario AM, Hammer GD.

Mol Cell Endocrinol. 2016 Feb 5;421:82-97. doi: 10.1016/j.mce.2015.11.031. Epub 2015 Dec 8. Review.


Development of adrenal cortex zonation.

Xing Y, Lerario AM, Rainey W, Hammer GD.

Endocrinol Metab Clin North Am. 2015 Jun;44(2):243-74. doi: 10.1016/j.ecl.2015.02.001. Review.


Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.

Nogueira TM, Lirov R, Caoili EM, Lerario AM, Miller BS, Fragoso MC, Dunnick NR, Hammer GD, Else T.

Horm Cancer. 2015 Aug;6(4):176-81. doi: 10.1007/s12672-015-0225-2. Epub 2015 May 29.


Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.

Fassnacht M, Berruti A, Baudin E, Demeure MJ, Gilbert J, Haak H, Kroiss M, Quinn DI, Hesseltine E, Ronchi CL, Terzolo M, Choueiri TK, Poondru S, Fleege T, Rorig R, Chen J, Stephens AW, Worden F, Hammer GD.

Lancet Oncol. 2015 Apr;16(4):426-35. doi: 10.1016/S1470-2045(15)70081-1. Epub 2015 Mar 18.


Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.

Sabolch A, Else T, Griffith KA, Ben-Josef E, Williams A, Miller BS, Worden F, Hammer GD, Jolly S.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):252-9. doi: 10.1016/j.ijrobp.2015.01.007. Epub 2015 Mar 5.


Hedgehog signaling and steroidogenesis.

Finco I, LaPensee CR, Krill KT, Hammer GD.

Annu Rev Physiol. 2015;77:105-29. doi: 10.1146/annurev-physiol-061214-111754. Review.


Regulation of the adrenocortical stem cell niche: implications for disease.

Walczak EM, Hammer GD.

Nat Rev Endocrinol. 2015 Jan;11(1):14-28. doi: 10.1038/nrendo.2014.166. Epub 2014 Oct 7. Review.


Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms.

Walczak EM, Kuick R, Finco I, Bohin N, Hrycaj SM, Wellik DM, Hammer GD.

Mol Endocrinol. 2014 Sep;28(9):1471-86. doi: 10.1210/me.2014-1060. Epub 2014 Jul 16. Erratum in: Mol Endocrinol. 2015 Dec;29(12):1805.


The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial.

Lerario AM, Worden FP, Ramm CA, Hesseltine EA, Stadler WM, Else T, Shah MH, Agamah E, Rao K, Hammer GD.

Horm Cancer. 2014 Aug;5(4):232-9. doi: 10.1007/s12672-014-0182-1. Epub 2014 May 22. Erratum in: Horm Cancer. 2014 Dec;5(6):424. Hasseltine, Elizabeth A [corrected to Hesseltine, Elizabeth A].


Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome.

Williams AR, Hammer GD, Else T.

Eur J Endocrinol. 2014 Jun;170(6):829-35. doi: 10.1530/EJE-13-1033.


Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.

Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal D, Wang G, Gonzalez M, Xu XS, Smit JW, Jiao J, Yu MK.

J Clin Endocrinol Metab. 2014 Aug;99(8):2763-70. doi: 10.1210/jc.2014-1258. Epub 2014 Apr 29.


Adrenocortical carcinoma.

Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD.

Endocr Rev. 2014 Apr;35(2):282-326. doi: 10.1210/er.2013-1029. Epub 2013 Dec 20. Review.


Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.

Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD.

J Clin Endocrinol Metab. 2014 Feb;99(2):455-61. doi: 10.1210/jc.2013-2856. Epub 2013 Dec 3.


Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M.

Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.


Genetics and epigenetics of adrenocortical tumors.

Lerario AM, Moraitis A, Hammer GD.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9. Review.


Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus.

Wood MA, Acharya A, Finco I, Swonger JM, Elston MJ, Tallquist MD, Hammer GD.

Development. 2013 Nov;140(22):4522-32. doi: 10.1242/dev.092775. Epub 2013 Oct 16.


An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome.

Raymond VM, Long JM, Everett JN, Caoili EM, Gruber SB, Stoffel EM, Giordano TJ, Hammer GD, Else T.

Clin Endocrinol (Oxf). 2014 Jun;80(6):925-7. doi: 10.1111/cen.12292. Epub 2013 Aug 5. No abstract available.


Adrenocortical carcinoma is a lynch syndrome-associated cancer.

Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB, Hammer GD, Stoffel EM, Greenson JK, Giordano TJ, Else T.

J Clin Oncol. 2013 Aug 20;31(24):3012-8. doi: 10.1200/JCO.2012.48.0988. Epub 2013 Jul 22. Erratum in: J Clin Oncol. 2013 Oct 1;31(28):3612.


Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex.

Krill KT, Gurdziel K, Heaton JH, Simon DP, Hammer GD.

Mol Endocrinol. 2013 May;27(5):754-68. doi: 10.1210/me.2012-1331. Epub 2013 Mar 21.


POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells.

França MM, Ferraz-de-Souza B, Santos MG, Lerario AM, Fragoso MC, Latronico AC, Kuick RD, Hammer GD, Lotfi CF.

Mol Cell Endocrinol. 2013 May 22;371(1-2):140-7. doi: 10.1016/j.mce.2012.12.029. Epub 2013 Jan 9.


Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.

Raymond VM, Else T, Everett JN, Long JM, Gruber SB, Hammer GD.

J Clin Endocrinol Metab. 2013 Jan;98(1):E119-25. doi: 10.1210/jc.2012-2198. Epub 2012 Nov 21.


Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy.

Miller BS, Gauger PG, Hammer GD, Doherty GM.

Surgery. 2012 Dec;152(6):1150-7. doi: 10.1016/j.surg.2012.08.024.


Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, Soares IC, Starnes E, Thomas DG, Latronico AC, Giordano TJ, Hammer GD.

Am J Pathol. 2012 Sep;181(3):1017-33. doi: 10.1016/j.ajpath.2012.05.026. Epub 2012 Jul 15.


Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma.

Miller BS, Ignatoski KM, Daignault S, Lindland C, Doherty M, Gauger PG, Hammer GD, Wang SC, Doherty GM; University of Michigan Analytical Morphomics Group.

World J Surg. 2012 Jul;36(7):1509-16. doi: 10.1007/s00268-012-1581-5.


Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma.

Simon DP, Giordano TJ, Hammer GD.

Clin Cancer Res. 2012 May 1;18(9):2452-64. doi: 10.1158/1078-0432.CCR-11-2371. Epub 2012 Mar 16.


Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Simon DP, Hammer GD.

Mol Cell Endocrinol. 2012 Mar 31;351(1):2-11. doi: 10.1016/j.mce.2011.12.006. Epub 2012 Jan 13. Review.


Adrenal cancer: clinical advances.

Hammer GD, Fassnacht M, Lalli E.

Horm Cancer. 2011 Dec;2(6):323. doi: 10.1007/s12672-011-0092-4. No abstract available.


Aged PROP1 deficient dwarf mice maintain ACTH production.

Nasonkin IO, Ward RD, Bavers DL, Beuschlein F, Mortensen AH, Keegan CE, Hammer GD, Camper SA.

PLoS One. 2011;6(12):e28355. doi: 10.1371/journal.pone.0028355. Epub 2011 Dec 1.


Adrenal cancer: scientific advances.

Hammer GD, Fassnacht M, Lalli E.

Mol Cell Endocrinol. 2012 Mar 31;351(1):1. doi: 10.1016/j.mce.2011.11.010. Epub 2011 Nov 15. No abstract available.


Evidence of adrenal failure in aging Dax1-deficient mice.

Scheys JO, Heaton JH, Hammer GD.

Endocrinology. 2011 Sep;152(9):3430-9. doi: 10.1210/en.2010-0986. Epub 2011 Jul 5.


Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma.

Dobrosotskaya IY, Hammer GD, Schteingart DE, Maturen KE, Worden FP.

Endocr Pract. 2011 May-Jun;17(3):e59-62. doi: 10.4158/EP10390.CR.


Adrenocortical stem and progenitor cells: unifying model of two proposed origins.

Wood MA, Hammer GD.

Mol Cell Endocrinol. 2011 Apr 10;336(1-2):206-12. doi: 10.1016/j.mce.2010.11.012. Epub 2010 Nov 20. Review.


Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA.

Kelly VR, Xu B, Kuick R, Koenig RJ, Hammer GD.

Mol Endocrinol. 2010 Dec;24(12):2281-91. doi: 10.1210/me.2010-0133. Epub 2010 Oct 13.


LRH-1 and Nanog regulate Dax1 transcription in mouse embryonic stem cells.

Kelly VR, Hammer GD.

Mol Cell Endocrinol. 2011 Jan 30;332(1-2):116-24. doi: 10.1016/j.mce.2010.10.003. Epub 2010 Oct 16.


Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.

Miller BS, Gauger PG, Hammer GD, Giordano TJ, Doherty GM.

Langenbecks Arch Surg. 2010 Sep;395(7):955-61. doi: 10.1007/s00423-010-0698-y. Epub 2010 Aug 9.


Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells.

Garcia-Perez JL, Morell M, Scheys JO, Kulpa DA, Morell S, Carter CC, Hammer GD, Collins KL, O'Shea KS, Menendez P, Moran JV.

Nature. 2010 Aug 5;466(7307):769-73. doi: 10.1038/nature09209.


GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.

Watson RL, Spalding AC, Zielske SP, Morgan M, Kim AC, Bommer GT, Eldar-Finkelman H, Giordano T, Fearon ER, Hammer GD, Lawrence TS, Ben-Josef E.

Neoplasia. 2010 May;12(5):357-65.


Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma.

Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM.

World J Surg. 2010 Jun;34(6):1380-5. doi: 10.1007/s00268-010-0532-2.


Supplemental Content

Loading ...
Support Center